12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Mon, 25 Aug 2025 04:26:05 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Server: cloudflare [5] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [6] => Vary: Accept-Encoding [7] => X-Powered-By: PHP/7.4.33 [8] => Cache-Control: no-cache, private [9] => X-Frame-Options: SAMEORIGIN [10] => X-Xss-Protection: 1; mode=block [11] => X-Content-Type-Options: nosniff [12] => Referrer-Policy: no-referrer-when-downgrade [13] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=6GxKWiw0MIAA8xPW%2FSpLirPezEtQ49ledYLsBclmP7j9EOeg%2F%2FEmGEPh%2BSoxE2Ss9fFIpadiZrPh8VYoXZND4XZmy3spxw2aOjaFunw%3D"}]} [14] => Cf-Cache-Status: DYNAMIC [15] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [16] => Server-Timing: cfEdge;dur=3,cfOrigin;dur=2 [17] => Set-Cookie: UpalLiveSession=eyJpdiI6IndTYVkrZjRPK0VxdEFwbDFGWmxXNmc9PSIsInZhbHVlIjoiSHc1QXNBZGxrWCt0MWo0WjZEUmIrSFRQTUQxWjlBUzk3WXBIQmRKT1k2eVk3b2hvTWtSWWJHY3dvTnNsOXdKNmJDNFdDQm5hSDE2SFh0bWtEK21MRVE9PSIsIm1hYyI6ImQ3Y2RmMzI4YTI3Yzg5Yzc5Mjg4N2M0ZjI1OWI5ZDJlN2VlNTY3ODkzOWNiOWY4YzU5N2E5ZDA4YTBjMGE0N2MifQ%3D%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Thu, 24 Aug 2028 04:21:17 GMT [18] => CF-RAY: 9748544a2c7a8a1d-KUL [19] => alt-svc: h3=":443"; ma=86400 ) 789

针对新加坡科学局宣布召回3种含有超标致癌物质的药物二甲双胍（metformin），我国卫生部周四发文告强调，我国并没批准发售这3种药物。

这3种药物包括Glucient XR Tablet 500mg、Meijumet Prolonged Release Tablet 750mg，以及Meijumet Prolonged Release Tablet 1000mg；有关药物是控制血糖的药物。

卫生总监拿督诺希山周四在文告中指出，卫生部对国家药品监管局（NPRA）注册的药物进行审查后发现，美国药物管制局共检验101项药物含有二甲双胍成份，然而只有获得注册的药物才获准在我国发售。

文告指，NDMA是亚硝胺基的杂质之一，通常含量较低。“根据国际癌症研究机构（IARC）显示，长期服用NDMA将增加患癌风险。”

“二甲双胍是一种治疗糖尿病以控制血糖的药物，平时可从医生或药剂师处获取。”

无论如何，国家药品监管局将继续监视市面上的药物，确保药物的质量、安全和有效性，并随时提醒民众。